Sanofi-Aventis Pays $190M To Settle Drug Price Case

Law360, New York (September 10, 2007, 12:00 AM EDT) -- French drug giant Sanofi-Aventis will hand over more than $190 million to settle claims by the U.S. Department of Justice and various states that its predecessor defrauded Medicare by inflating the reported average wholesale price of a cancer drug.

The settlement, announced Monday, resolves claims against Aventis Pharmaceuticals Inc. in the massive antitrust class action consolidated in 2003 in the U.S. District Court for the District of Massachusetts alleging a bunch of big-name drug makers bilked the U.S. government and consumers by artificially boosting the prices...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.